A MULTICENTER ASSESSMENT OF SURVIVAL IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC) WHO RECEIVED IMMUNE CHECKPOINT INHIBITOR THERAPY (ICI) WITH OR WITHOUT CYTOREDUCTIVE NEPHRECTOMY (CN)

被引：0
|
作者：
Gross, Evan
Li, Mingjia
Yin, Ming
Orcutt, Delaney
Hussey, Duncan
Trott, Elliot
Kramer, Joel
Oliva, Kaylee
Gore, John
Schade, George
Lin, Daniel
Tykodi, Scott
Hall, Evan
Thompson, John
Parikh, Anish
Yang, Yuanquan
Collier, Katharine
Miah, Abdul
Mori-Vogt, Sherry
Hinkley, Megan
Mortazavi, Amir
Monk, Paul
Folefac, Edmund
Clinton, Steven
Psutka, Sarah
机构：
来源：
JOURNAL OF UROLOGY | 2021年 / 206卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP14-08
引用
收藏
页码：E255 / E255
页数：1
相关论文
共 50 条
  • [11] The role of cytoreductive nephrectomy (CN) in the immune checkpoint inhibitor (ICI) era of metastatic renal cell carcinoma (mRCC): A systematic review and individual patient data (IPD) meta-analysis of 2319 patients
    Makrakis, Dimitrios
    Msaouel, Pavlos
    Karam, Jose A.
    Esagian, Stepan M.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 425 - 425
  • [12] RACIAL DIFFERENCES IN OUTCOMES FOR METASTATIC RENAL CELL CARCINOMA (MRCC) PATIENTS MANAGED ON IMMUNE-CHECKPOINT INHIBITOR (ICI) THERAPY
    Olsen, T. Anders
    Martini, Dylan
    Goyal, Subir
    Liu, Yuan
    Evans, Sean
    Magod, Benjamin
    Brown, Jacqueline
    Yantorni, Lauren
    Russler, Greta
    Caulfield, Sarah
    Goldman, Jamie
    Nazha, Bassel
    Harris, Wayne
    Master, Viraj
    Kucuk, Omer
    Carthon, Bradley
    Bilen, Mehmet
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A133 - A133
  • [13] Cytoreductive nephrectomy (CN) for patients with metastatic sarcomatoid and/or rhabdoid (S/R) renal cell carcinoma (RCC) treated with immune checkpoint inhibitors (ICI)
    Hahn, A. W.
    Viscuse, P. V.
    Pieretti, A.
    Wiele, A. J.
    Jonasch, E.
    Gao, J.
    Zurita, A. J.
    Shah, A. Y.
    Campbell, M. T.
    Sharma, P.
    Wood, C. G.
    Tannir, N. M.
    Karam, J. A.
    Msaouel, P.
    ANNALS OF ONCOLOGY, 2021, 32 : S699 - S700
  • [14] Preoperative sorafenib (Sor) and cytoreductive nephrectomy (CN) in metastatic renal cell carcinoma (mRCC)
    Finelli, A.
    Horgan, A. M.
    Evans, A.
    Kim, T. K.
    Durrant, K.
    Yap, S.
    Cassol, C. A.
    Dubinski, W.
    Fleshner, N.
    Jewett, M. A. S.
    Joshua, A. M.
    Sridhar, S. S.
    Zlotta, A.
    Knox, J. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [15] External validation of a prediction model of survival after cytoreductive nephrectomy (CN) for metastatic renal cell carcinoma (mRCC).
    Bex, Axel
    van Werkhoven, Erik D.
    Noe, Allard
    Karam, Jose A.
    Matin, Surena F.
    Margulis, Vitaly
    Stewart, Grant
    Staehler, Michael D.
    Wood, Christopher G.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [16] Cytoreductive Nephrectomy for Patients with Metastatic Sarcomatoid and/or Rhabdoid Renal Cell Carcinoma Treated with Immune Checkpoint Therapy
    Hahn, Andrew W.
    Kotecha, Ritesh R.
    Viscuse, Paul V.
    Pieretti, Alberto C.
    Wiele, Andrew J.
    Jonasch, Eric
    Lee, Chung-Han
    Gao, Jianjun
    Zurita, Amado J.
    Shah, Amishi Y.
    Campbell, Matthew T.
    Sharma, Padmanee
    Motzer, Robert J.
    Russo, Paul
    Wood, Christopher G.
    Tannir, Nizar M.
    Voss, Martin H.
    Karam, Jose A.
    Hakimi, A. Ari
    Msaouel, Pavlos
    EUROPEAN UROLOGY FOCUS, 2023, 9 (05): : 734 - 741
  • [17] Salvage immune checkpoint inhibitor (ICI) plus tyrosine kinase inhibitor (TKI) combination therapy for metastatic renal cell carcinoma (mRCC).
    Parikh, Anish B.
    Psutka, Sarah P.
    Yang, Yuanquan
    Collier, Katharine
    Miah, Abdul
    Li, Mingjia
    Mori-Vogt, Sherry
    Hinkley, Megan
    Orcutt, Delaney
    Trott, Elliott
    Gross, Evan
    Hussey, Duncan
    Kramer, Joel
    Oliva, Kaylee
    Mortazavi, Amir
    Monk, Paul
    Folefac, Edmund
    Clinton, Steven K.
    Yin, Ming
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [18] Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor (ICI) response in metastatic renal cell carcinoma (mRCC).
    Zhu, Jason
    Pabla, Sarabjot
    Labriola, Matthew
    Gupta, Rajan T.
    McCall, Shannon
    George, Daniel J.
    Dressman, Devin
    Glenn, Sean T.
    Nesline, Mary
    George, Saby
    Morrison, Carl
    Zhang, Tian
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [19] Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor (ICI) response in metastatic renal cell carcinoma (mRCC).
    Zhu, Jason
    Pabla, Sarabjot
    Labriola, Matthew
    Gupta, Rajan T.
    McCall, Shannon
    George, Daniel J.
    Dressman, Devin
    Glenn, Sean
    Nesline, Mary
    George, Saby
    Morrison, Carl
    Zhang, Tian
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [20] Evaluation of tumor microenvironment and biomarkers of immune checkpoint inhibitor (ICI) response in metastatic renal cell carcinoma (mRCC).
    Zhu, Jason
    Pabla, Sarabjot
    Labriola, Matthew
    Gupta, Rajan T.
    McCall, Shannon
    George, Daniel J.
    Dressman, Devin
    Glenn, Sean
    George, Saby
    Morrison, Carl
    Zhang, Tian
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345